Australia, May 5 -- Amgen Inc., owns the trademark (2494020) for 'MARITIDE' till Oct. 28, 2034.
Status: registered:
Registered/protected
Classes: 5 [Pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders, metabolic diseases and disorders, and obesity; Pharmaceutical preparations for weight reduction and long-term weight loss maintenance.] and 5 [Pharmaceutical preparations;Pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders, metabolic diseases and disorders, and obesity;Pharmaceutical preparations for weight reduction and long-term weight loss maintenance]
Type of Mark: Word
Date of Acceptance: Feb. 24
Registration Advertised: May 4
For further details contact Spruson & Ferguson.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2494020.
Disclaimer: Curated by HT Syndication.
